WO2003020915A2 - Non-linear amplitude dielectrophoresis waveform for cell fusion - Google Patents

Non-linear amplitude dielectrophoresis waveform for cell fusion Download PDF

Info

Publication number
WO2003020915A2
WO2003020915A2 PCT/US2002/008239 US0208239W WO03020915A2 WO 2003020915 A2 WO2003020915 A2 WO 2003020915A2 US 0208239 W US0208239 W US 0208239W WO 03020915 A2 WO03020915 A2 WO 03020915A2
Authority
WO
WIPO (PCT)
Prior art keywords
electric field
fusion
amplitude
waveform
cells
Prior art date
Application number
PCT/US2002/008239
Other languages
French (fr)
Other versions
WO2003020915A3 (en
Inventor
Richard E. Walters
Derin C. Walters
Alan D. King
Original Assignee
Cyto Pulse Sciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyto Pulse Sciences, Inc. filed Critical Cyto Pulse Sciences, Inc.
Priority to US10/487,235 priority Critical patent/US6916656B2/en
Priority to DE60226501T priority patent/DE60226501D1/en
Priority to AU2002254269A priority patent/AU2002254269A1/en
Priority to JP2003525619A priority patent/JP4217618B2/en
Priority to CA2458610A priority patent/CA2458610C/en
Priority to EP02723493A priority patent/EP1472358B1/en
Publication of WO2003020915A2 publication Critical patent/WO2003020915A2/en
Publication of WO2003020915A3 publication Critical patent/WO2003020915A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/02—Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L2224/00—Indexing scheme for arrangements for connecting or disconnecting semiconductor or solid-state bodies and methods related thereto as covered by H01L24/00
    • H01L2224/80—Methods for connecting semiconductor or other solid state bodies using means for bonding being attached to, or being formed on, the surface to be connected
    • H01L2224/83—Methods for connecting semiconductor or other solid state bodies using means for bonding being attached to, or being formed on, the surface to be connected using a layer connector
    • H01L2224/838—Bonding techniques
    • H01L2224/8385—Bonding techniques using a polymer adhesive, e.g. an adhesive based on silicone, epoxy, polyimide, polyester
    • H01L2224/83855—Hardening the adhesive by curing, i.e. thermosetting
    • H01L2224/83856—Pre-cured adhesive, i.e. B-stage adhesive
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L2924/00—Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
    • H01L2924/01—Chemical elements
    • H01L2924/01019—Potassium [K]

Definitions

  • the present invention relates generally to methods and apparatus for fusing biological cells to one another. More specifically, the present invention provides methods and apparatus for treating biological cells with electrical fields, such that the biological cells are aligned and have increased cell membrane contact prior to being subjected to cell fusion.
  • a neutrally charged biological cell is placed i'n a uniform electric field, such as provided by a pair of electrodes which are both planar, the biological cell does not move toward one electrode or another because the attractive forces from both electrodes are the same.
  • a neutrally charged biological cell is placed in a non-uniform electric field, such as provided by two electrodes which are both not planar, ; as shown in PRIOR ART Fig. 1, the biological cell forms a dipole, is attracted to one electrode with greater attractive force than the other, and moves towards the electrode having the greater attractive force.
  • dielectrophoresis Such a use of a non-uniform electric field is used in dielectrophoresis, and the concept of using- dielectrophoresis to align living cells, followed by a fusion/electroporation pulse, to fuse cells has been in the literature since early 1970 's. This process is used to produce hybrids of two different cell types for therapeutic purposes, for hybridoma production for producing monoclonal antibodies, for nuclear fusion, and for producing other hybrid cells. Dielectrophoresis Is the process of applying an electrical force on neutrally charged particles such as living cells . The force from dielectrophoresis results from applying a non-uniform electric field that separates charges inside the cells forming a dipole.
  • the non-uniform electric field moves the cells towards the highest or lowest electric field intensity. This movement is dependent on the relative conductivities and permittivities of the medium and the biological cells or particles.
  • the dielectrophoretic force is a function of the electric field squared so electric field polarity " is not important. The force is a function of the relative conductivities and permitivities of the medium and the particles or cells. The conductivities and permitivities are also a function of frequency of the applied electric field " .
  • an AC voltage wave such as a sine wave, is applied across electrodes to produce this alternating electric field.
  • the sine wave voltage, frequency, and duration are optimized for specific cell types.
  • one or more fusion/electroporation pulses are applied ' to form pathways in the cell membranes in which membranes from both cells commingle. These pathways permit the contents of the cells to mix forming a hybrid cell.
  • another AC field can"be applied to hold the cells together while the fused cells stabilize.
  • the AC voltage has been linearly increased or decreased to prevent damage to the cells due to a sudden application of a field.
  • Examples of cell fusion applications include hybridoma production and nuclear transfer.
  • a recent application for electrofusion is to produce therapeutic hybrids for cancer immunotherapy. These hybrids are produced from cancer tumor cells an -immune' system dendritic cells in an ex vivo process. Each treatment requires a large number of viable hybrids, which results in a new requirement for high efficiency in the hybrid production process.
  • Fig. 5 illustrates an overall general PRIOR ART protocol for carrying out cell fusion"using- electric field waveforms, wherein a pre- fusion electric field waveform is followed by a fusion/electroporation pulse, which is followed by a post- fusion electric field waveform.
  • pre-fusion electric field waveforms were provided for biological cells which increases cell fusion efficiency over biological cells treated with a constant amplitude or a linearly increasing amplitude pre-fusion electric field waveform.
  • Fig. 2E of Chang discloses a linear low voltage presine AC waveform, a high voltage linear electroporating AC waveform, and a low voltage linear post-pora ion AC waveform.
  • the invention of Chang is confined solely to the fusion/electroporatidn pulses.
  • Chang discloses only a linear, low voltage presine AC waveform.
  • Chang does not disclose a non-linear low voltage presine AC waveform.
  • Chang does not focus- attention on the presine AC waveform, other than a nominal statement therepf .
  • The- first rocess in any cell fusion- ⁇ system is" to bring the cells into contact.
  • the non-uniform electric field is produced by the electrode device.
  • the non-uniformity is a function of the- electrode--conf ⁇ g ⁇ ratlon,' as: showir in--PRIOR ART Figs". 1 and 2.
  • the cell types to be fused are placed in a low conductive medium (less than 0.01 S/m) to minimize ohmic heating that may harm the cells and that causes turbulence thus reducing the number, of fused hybrids. In this respect, it would be desirable for biological cells being subjected cell fusion.. o,. e treated so as to reduce heating during cell alignment and cell membrane contact.
  • the waveform generator has two functions. The first is to produce the AC voltage waveform that is converted into an AC field by the electrod device. This AC field then brings the cells into alignment/contact. The second function is to produce a pulse voltage that electroporates the cell membrane, fusing the cells. In some cases another AC voltage is produced, a ter the fusing pulse ' to hold the cells in alignment until the fusion products become viable or stable.
  • a first reason is a mechanical reason. That is, immediate application of a high amplitude alignment waveform causes extreme force to be exerted on the cells, causing the cells to move rapidly towards an electrode. This- rapid cell movement causes turbulence forces in the medium surrounding the cells. The turbulence forces do not "allow complete pearl chains' of cells' to"form,- and")the turbulence forces cause already formed pearl chains of cells to break up.
  • a second reason why it is not desirable to- immediately provide a high amplitude alignment waveform to cells that are to undergo cell fusion is that such a h ⁇ jgh amplitude alignment waveform causes heating to occur in the media in which the biological cells are suspended. Heating also causes turbulence which does not permit complete pearl chains of aligned cells to form and causes already formed pearl chains to break up. The heat in the heated up media also reduces cell viability.
  • the present invention is an improvement over the current art.
  • a non-linear- voltage waveform having a non-linear change in amplitude is- applied"to' biological, cells: before'.application”of one or more cell fusion/electroporation pulses.
  • the present invention first brings about or. forces tangential, membrane contact and alignment between adjacent cells as a result of' applying-th 'non-linear' voltage..',waveluxm.''' Then, the present invention brings about or forces close membrane contact between adjacent cells as a result of further application of the non-linear voltage waveform.
  • the' biological cells • ID' are compressed' • against- each other under the influence of the waveform with a nonlinear change in amplitude.
  • the biological cells can.be similar Eukaryotic cells, or they can be dissimilar Eukaryotic cells".
  • the pre-fusion non-linear voltage waveform which changes' in"amplitude ln"a' non-linear' way, can"be"a' nonlinear AC voltage waveform.
  • the AC electric field waveforms can include sine waves.
  • a " parameter of the- non-linearity of the change in amplitude of the waveform can 'be ' set so' that the'f sion- process' can"be”op imized "by cell type. With the amplitude of the AC waveform varyirilg non-linearly in amplitude over time, the biological cells align and fuse with lower energy (less heating) and with higher fusion"efficiency.
  • the pre-fusion electric field waveform includes a relatively low amplitude, long duration electric field waveform followed by a relatively short duration, high amplitude electric field waveform. More specifically, the relatively low amplitude, long duration electric field waveform slowly facilitates pearl chain' formation and alignment of biological cells without-, causing turbulence or cell death. Once the cells are aligned and in pearl chains, a relatively high amplitude, short duration pre-fusion electric field waveform is applied to the biological cells. The cells are already ⁇ in alignment, and for a short period of time, before heating occurs, cell compression takes place without turbulence.
  • the pre-fusion electric field waveform amplitude can change in a stepped non-linear way with respect to time.
  • the pre-fusion electric field waveform can change in amplitude in a continuous non-linear way with respect • to time.
  • the pre-fusion electric field waveform includes an AC electric field waveform which changes in amplitude in" a non-linear way with respect to time.
  • the amplitude of the AC electric field waveform can change in a non-linear way with respect to time in accordance with a non-linear algorithm.
  • the AC electric field waveforms have an AC waveform electric field intensity between 10 volts/cm and " 1, 000 ' volts/cm-.
  • the non-linear step-wise amplitude increasing waveforms can be applied as pre-fusion electric field' waveforms in either adjacent steps or non-adjacent steps.
  • the biological cells are subjected, to a cell fusion pulse.
  • the biological cells can be treated with a non-linear AC electric field waveform following the qell fusion pulse.
  • a non-linear waveform whose amplitude changes in a non-linear way with respect to time such as wherein a pre-fusion type of AC, amplitude changes with time.
  • algorithms "that can be used for the non-linear change in amplitude over time include exponential, logarithmic, polynomial, power function, step function, sigmoid function, and non-linear algorithms generally, etc.
  • an object of the present- invention is to provide a new and improved non-linear pre- fusion electric field waveform whose amplitude changes in a non-linear way with respect to time as a dielectrophoresis waveform prior to cell fusion.
  • Another object of the invention is to provide a nonlinear dielectrophoresis waveform for cell fusion in which AC electric field waveforms applied to the biological cells increase cell fusion efficiency over biological cells treated with a constant amplitude or a linearly increasing amplitude pre-fusion electric field waveform.
  • Yet another object of the present invention is to provide a new and improved non-linear dielectrophoresis waveform for cell fusion which reduces heating of biological cells being treated with pre-fusion electric field waveforms, for increasing cell alignment and cell membrane contact prior to being subjected to cell fusion.
  • Still another object of the present invention is to provide a new and improved non-linear dielectrophoresis waveform for cell fusion that avoids the mechanical forces, turbulence, and heating which result when the biological cells are subjected to a cell fusion from immediately applying a high amplitude alignment waveform to biological cells that are to undergo cell fusion.
  • Even another object of the present invention is uo provide a new and improved non-linear dielectrophoresis waveform for cell fusion that increases cell membrane contact between biological cells treated witlr pre-fusion electric field waveforms prior to undergoing cell fusion.
  • Fig. 1 illustrates PRIOR ART dipole formation in biological cells under the influence of a non-uniform electric field created by non-symmetrical electrodes.
  • Fig. 2 illustrates a PRIOR ART path of movement of a biological cell in a non-uniform electric field created by non-symmetrical electrodes and also illustrates pearl chain alignment and formation of biological cells.
  • Fig. 3 illustrates PRIOR ART a constant amplitude pre-fusion electric field waveform.
  • Fig- 4 illustrates PRIOR ART a linearly increasing amplitude pre-fusion electric field waveform.
  • Fig. 5 illustrates an overall general PRIOR ART protocol for • carryin ' out cell fusion' using- electric''f ⁇ d waveforms, wherein a pre-fusion electric field waveform is followed by a fusion/electroporation pulse, which is followed by a post-fusion electric field waveform.
  • Fig. 6 shows independent" biological cells"prior) to i applying non-linear dielectrophoresis waveforms of the invention.
  • Fig. 7 shows tangentially contacting biological, cells in pearl chain alignment during application of' a relatively low amplitude, long duration pre-fusion electric field waveform of the invention.
  • Fig. 8 shows closely contacting and compressed- biological cells during application of a relatively high amplitude, short duration pre-fusion electric field- waveform of the invention, following the application of the relatively low amplitude, long duration pre-fusion electric field waveform that was applied in Fig. 7.
  • Fig. 9 shows variations in pre-fusion electric field waveforms applied to biological cells using a power function having variations in the constant "k" of the-, power function. It is noted that for each selection of the constant "k”, there is a relatively low amplitude-, long duration pre-fusion electric field waveform portion followed by a relatively high amplitude, short duration pre-fusion electric field waveform portion.
  • Fig. 10 shows a selected "k" modulated non-linear increasing continuous AC waveform applied as a pre-fusi ⁇ n electric field AC waveform as a power function with a selected power function constant "k" shown in Fig. 9, a relatively low amplitude, long duration pre-fusion- electric field waveform portion is shown followed by " a relatively high amplitude, short duration pre-fusion electric field waveform portion.
  • Fig. 11 shows non-linear sigmoidally shaped waveforms applied as pre-fusion electric field waveforms, wherein a transition from a relatively low amplitude, long duration pre-fusion electric field waveform to a relatively high amplitude, short duration pre-fusion electric field waveform is relatively slow.
  • Fig. 12 shows non-linear sigmoidally shaped" waveforms applied as pre-fusion electric field waveforms, wherein a transition from a relatively low amplitude, long duration pre-fusion electric field waveform to a relatively high amplitude, short duration pre-fusion electric field waveform is relatively fast.
  • FIG. 13" shows non-linear step-wise increasing- waveforms applied as pre-fusion electric field waveforms, wherein the pre-fusion electric field ' waveforms are' provided as non-adjacent steps, wherein a first pre-fusion electric field waveform is a relatively low amplitude, long duration pre-fusion electric field waveform, wherein an off-time is provided, and wherein a second pre-fusion electric field waveform is a relatively high amplitude, short duration pre-fusion electric field waveform.
  • FIG. 14 shows non-linear step-wise increasing waveforms applied as pre-fusion electric field " aveforms, wherein the pre-fusion electric field waveforms are provided as adjacent steps, wherein a first pre-fusion electric field waveform is a relatively low amplitude, long duration pre-fusion electric field waveform, and wherein a second pre-fusion electric field waveform is a relatively hig amplitude, short duration pre-fusion' electric field waveform and is applied immediately after the first pre-fusion electric field ' waveform.
  • a method and apparatus are provided for non-linear dielectrophoresis waveform for cell fusion, and with reference to the drawings, said method and apparatus are described below.
  • the present invention is an improvement over the current 'art.
  • a non-linear voltage waveform whose amplitude changes in a non-linear way, is applied to biological cells' before application of one or more cell fusion pulses. Separated biological cells 10 are shown in Fig. 6.
  • the present invention first brings about or forces tangential membrane contact betwe ' en adjacent cells'as' a "result' of' applying-"the' non-linear voltage waveform, as shown in Fig. 7.
  • the present invention brings about or forces close membrane contact between adjacent cells as a result of applying the noh- linear"voltage waveform", as' shown"in' Fig-.' 8'.
  • the biological cells 10 are compressed against each other under the influence of the non-linear voltage waveform.
  • the non-linear"voltage ⁇ waveformy • ⁇ whose' • amplit j ude changes in a non-linear way, can be a non-linear AC voltage waveform.
  • a parameter of the non-linearity of the waveform can be set so that the fusion process can be optimized"'bycell type. With" he amplitude' of the' AC waveform varying non-linearly over time, the biological cells align and fuse with lower energy (less heating) and with higher fusion efficiency.
  • a non-linear AC voltage waveform preferably the non-linear AC ' voltage waveform has a relatively low AC voltage- amplitude at the first portion of the waveform that brings the biological' cells into' close proximity and' alignment .
  • a second portion of the waveform then increases in amplitude just before the fusion pulse is to be applied. This increase in amplitude produces a short-term, intense, and"non-uniform"electric field, which' forces' the biological cells into close contact. Heating is reduced, due to the lower voltage used for alignment and t.he shorter duration intense AC portion.
  • this non-linear waveform is a power function that may be represented by the following mathematical formula or algorithm.
  • the total AC waveform duration, the AC starting amplitude, the AC stopping amplitude and the power exponent "k" are all optimized for" the cells type bejLng used.
  • the invention provides a relatively low amplitude, long duration pre-fusion electric field waveform that produces a lower intensity electric field to align the biological cells and that then provides a , relatively high amplitude, short duration pre-fusi n electric field waveform of increased electric field- intensity to force the cells into close contact, just before- the AC wave ends and the cell fusion/electroporation pulses begins.
  • This non-linear change in amplitude approach of the invention also produces less heating and less turbulence, which further provide an increase in cell hybrid production and production efficiency.
  • Fig. 11 shows non-linear sigmoidally shaped waveforms, whose amplitudes change in a non-linear way, applied as pre-fusion electric field waveforms, wherein " a transition from a relatively low amplitude, long duration pre-fusion electric field waveform to a relatively high amplitude, short duration pre-fusion electric field waveform is relatively slow.
  • Fig. 12 shows non-linear sigmoidally shaped waveforms, whose amplitudes change in a non-linear way, applied as pre-fusion electric field waveforms, wherein a transition from a relatively low amplitude, long duration pre-fusion electric field wavef ⁇ r ⁇ r to a relatively high amplitude, short duration pre-fusion electric field waveform is relatively fast.
  • FIG. 13 shows non-linear step-wise increasing waveforms, whose amplitudes change in a non-linear way, applied as pre-fusion electric field waveforms, wherein the pre-fusion electric field waveforms are provided as non-adjacent steps, wherein a first pre-fusion electric field waveform is a relatively low amplitude, long duration pre-fusion electric field waveform, wherein " an off-time is provided, and wherein a second pre-fusion, electric field waveform is a relatively high amplitude, short duration pre-fusion electric field waveform , .
  • FIG. 14 shows non-linear step-wise increasing waveforms, whose amplitudes change in a non-linear way, applied as pre-fusion electric field waveforms, wherein the pre-fusion electric field waveforms are provided as adjacent steps, wherein a first pre-fusion electric field waveform is a relatively low amplitude, long duration pre- fusion electric field waveform, and wherein a second pre- fusion electric field waveform is a relatively high amplitude, short duration pre-fusion electric field waveform and is applied immediately after the first p
  • the present invention can be carried out by an- apparatus that delivers such pre-fusion electric field wavefor s described above.
  • a software ' modification has been made to the Cyto Pulse PA-4000' system with the PA-101 AC waveform generator.
  • This Cyto Pulse Sciences, Inc. PulseAgil ' e(Reg. UIS. Pat. and Trtr. Off.) system software now produces this waveform (see U. S. Patent 6, 0X0, 613 incorporated herein by reference).
  • the non-linear AC waveform parameters are inputted by the user, and the computer generates the AC waveforms (pre- fusion electric field waveforms) and fusion pulse waveforms (electroporation waveforms) .
  • the procedure consisted of the following steps. Cells were centrifuged and re-suspended in 10 milliliters of Cyto Pulse commercial Cytofusi ⁇ n medium (formula C) The cells were washed twice in the same medium and re-suspended in Cytofusion medium after the washes. Cells were counted and the cell concentration was adjusted to " 8 million cells/milliliter. Equal volumes of A54 ' 9 cells and dendritic cells were mixed. Three milliliters of cell suspension was place into a 6 milliliter capacity coaxial cell fusion electrode, having an internal cylindrical anode of 3.9 cm diameter with a gap of 4 mm from the cathode. The following cell fusion protocols were applied.
  • Second pre-fusion electric field waveform 75 V to 75, V. 10 seconds, 0.8 MHz Fusion/electroporation pulse IX 800 V, 40 microseconds Post fusion/electroporation pulse 45 V to 45 V, 50 seconds, 0.8 MHz-
  • Group C (Control--no electricity) After fusion, cells were left undisturbed for 30 minuses to allow fusion maturation. Three milliliters of tissue culture medium with 10% fetal bovine serum were added to the cell suspension in the cell fusion electrode. Fifteen minutes later the cells were harvested for analysis.
  • Results are shown in the TABLE below in which percentages' of "fused "cells' are” presented" for"mixed"A549- and dendritic cells in Group A (which were treated with ' a pre-fusion electric field waveform of the invention prior to cell fusion) , for mixed A549 and dendritic cells in Group B (which "were treated by a" prior art pre-fusion electric field waveform prior to cell fusion) , and for mixed A549 and dendritic cells in Group C (which were not treated by any pre-fusion electric field waveform at ail prior- to cell fusion) .
  • the first column lists the respective groups of A549 and dendritic cells (den.) that were subjected to fusion treatment.
  • The- second column lists the percentages of fused cells formed by the fusion of an A549 " cell with another A54 cell.
  • the third column lists percentages of fused cells formed by the fusion of a dendritic cell with another dendritic cell .
  • the fourth column lists percentages of fused cells formed by the fusion of a dendritic cell with an A549 cell.
  • non-linear dielectrophoresis- waveforms for cell fusion which may advantageously be used to provide pre-fusion electric field waveforms for biological cells which increase cell fusion efficiency over biological cells treated with a constant amplitude or a linearly increasing amplitude pre-fusion electric field waveform.
  • non-linear dielectrophoresis waveforms avoid the mechanical forces, turbulence, and heating which result from immediately applying a high amplitude alignment waveform to biological cells that are to undergo cell fusion.
  • non-linear dielectrophoresis waveforms reduce heating of biological cell's being treated with pre-fusion electric field waveforms for increasing cell alignment and cell membrane contact prior to being subjected to cell fusion.
  • non-linear dielectrophoresis waveforms increase cell membrane contact between biological cells treated with pre-fusion electric field waveforms prior to undergoing cell fusion.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Electromagnetism (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

An object of the invention is to provide a method of treating biological cells prior to subjecting the biological cells to cell fusion pulses which includes the step of treating the biological cells with pre-fusion electric field waveforms which change amplitude in a non-linear way with respect to time, such that the biological cells are first aligned with a relatively low amplitude, long duration pre-fusion electric field waveform and then compressed with a relatively high amplitude, short duration pre-fusion electric field waveform resulting in increased cell membrane contact prior to being subjected to cell fusion. The non-linear pre-fusion electric field waveforms can change in a stepped way, in a continuous way, in a sigmoidal way, with step-wise increasing waveforms in adjacent steps, with step-wise increasing waveforms in non-adjacent steps, and in accordance with non-linear algorithms.

Description

NON-LINEAR AMPLITUDE DIELECTROPHORESIS WAVEFORM
FOR CELL FUSION
Cross-Reference to Related Application This application claims priority based upon copending United States Provisional Application Serial No. 60/315,936, filed 31 August 2001.
Technical Field The present invention relates generally to methods and apparatus for fusing biological cells to one another. More specifically, the present invention provides methods and apparatus for treating biological cells with electrical fields, such that the biological cells are aligned and have increased cell membrane contact prior to being subjected to cell fusion.
Background Art If a neutrally charged biological cell is placed i'n a uniform electric field, such as provided by a pair of electrodes which are both planar, the biological cell does not move toward one electrode or another because the attractive forces from both electrodes are the same. On the other hand, if a neutrally charged biological cell is placed in a non-uniform electric field, such as provided by two electrodes which are both not planar, ; as shown in PRIOR ART Fig. 1, the biological cell forms a dipole, is attracted to one electrode with greater attractive force than the other, and moves towards the electrode having the greater attractive force.
Such a use of a non-uniform electric field is used in dielectrophoresis, and the concept of using- dielectrophoresis to align living cells, followed by a fusion/electroporation pulse, to fuse cells has been in the literature since early 1970 's. This process is used to produce hybrids of two different cell types for therapeutic purposes, for hybridoma production for producing monoclonal antibodies, for nuclear fusion, and for producing other hybrid cells. Dielectrophoresis Is the process of applying an electrical force on neutrally charged particles such as living cells . The force from dielectrophoresis results from applying a non-uniform electric field that separates charges inside the cells forming a dipole. After the dipole has been formed, the non-uniform electric field then moves the cells towards the highest or lowest electric field intensity. This movement is dependent on the relative conductivities and permittivities of the medium and the biological cells or particles. The dielectrophoretic force is a function of the electric field squared so electric field polarity "is not important. The force is a function of the relative conductivities and permitivities of the medium and the particles or cells. The conductivities and permitivities are also a function of frequency of the applied electric field". Typically, an AC voltage wave, such as a sine wave, is applied across electrodes to produce this alternating electric field. The sine wave voltage, frequency, and duration are optimized for specific cell types. After the AC wave is applied to align the cells, one or more fusion/electroporation pulses are applied'to form pathways in the cell membranes in which membranes from both cells commingle. These pathways permit the contents of the cells to mix forming a hybrid cell. Following the fusion pulses, another AC field can"be applied to hold the cells together while the fused cells stabilize. In some cases, the AC voltage has been linearly increased or decreased to prevent damage to the cells due to a sudden application of a field. Examples of cell fusion applications include hybridoma production and nuclear transfer. A recent application for electrofusion is to produce therapeutic hybrids for cancer immunotherapy. These hybrids are produced from cancer tumor cells an -immune' system dendritic cells in an ex vivo process. Each treatment requires a large number of viable hybrids, which results in a new requirement for high efficiency in the hybrid production process.
There are a number of techniques (electrical, mechanical, chemical) available to perform cell fusion. This invention relates to electrical means . The current electric art uses a voltage waveform. generator connected to an electrode device. With respect to relevant known electrical, mechanical, and chemical techniques, the" following U.S. Patents and published PCT application are of particular interest and are incorporated herein by referenge:
4,326,934 April 27, 1982 Pσhl
4,441,972 April 10,1982 Pdhl
4,764,473 August 16, 1988 Matschke et al 4,784,954 November 15, 1988 Zimmermann
5,304,486 April 19, 1994 Chang
6,010,613 January 4, 2000 Walters et al
WO' 00/60065' October 12, 2000' Walters et al
From the above, it is known to use pre-fusion electric ield waveforms- that" have either a' constant amplitude, see PRIOR ART Fig. 3, or a linearly increasing amplitude, see PRIOR ART Fig. 4. Fig. 5 illustrates an overall general PRIOR ART protocol for carrying out cell fusion"using- electric field waveforms, wherein a pre- fusion electric field waveform is followed by a fusion/electroporation pulse, which is followed by a post- fusion electric field waveform.
Nevertheless, efficiency of" cell fusion following a constant amplitude or a linearly increasing amplitude of pre-fusion electric field waveforms cannot deliver the higher efficiencies required in such applications as therapeutic hybrid production' for cancer'immuπotherapy. In this respect, it would be desirable if pre-fusion electric field waveforms were provided for biological cells which increases cell fusion efficiency over biological cells treated with a constant amplitude or a linearly increasing amplitude pre-fusion electric field waveform.
More specifically with respect to U. S. Patent No. 5,304,486 of Chang, it is noted that Fig. 2E of Chang discloses a linear low voltage presine AC waveform, a high voltage linear electroporating AC waveform, and a low voltage linear post-pora ion AC waveform. The invention of Chang is confined solely to the fusion/electroporatidn pulses. Chang discloses only a linear, low voltage presine AC waveform. Chang does not disclose a non-linear low voltage presine AC waveform. Chang does not focus- attention on the presine AC waveform, other than a nominal statement therepf . The- first rocess in any cell fusion-■ system"is" to bring the cells into contact. In any case, sufficient force must be applied to each cell to overcome the negative surface charge. Merely applying a uniform electric field: will nσtmσver a cell because' the"net- charge of the cell is zero. Thus from the definition of electric field, there is no force applied
Force = (Electric Field) * (Charge) However, a non-unlfornr field -moves: the"positive iσms inside each cell to one side and the negative ions to the opposite side producing a dipole, as shown in PRIOR ART Fig. 1. Once the dipole is induced, a net force is exerted on' the"cell because:' ttrer. irtteits±ty of- the"field" s greater on one side than the other. The movement of cells in one direction causes the cells to concentrate in all area. Since the cells are now dipoles, the negative side of one- cell will attract' the' pαs±tive- side- of- another cell overcoming the negative surface charge, as shown in PRIOR ART'Fig. 2. The non-uniform electric field is produced by the electrode device. The non-uniformity is a function of the- electrode--conf±gαratlon,' as: showir in--PRIOR ART Figs". 1 and 2. Generally, the cell types to be fused are placed in a low conductive medium (less than 0.01 S/m) to minimize ohmic heating that may harm the cells and that causes turbulence thus reducing the number, of fused hybrids. In this respect, it would be desirable for biological cells being subjected cell fusion.. o,. e treated so as to reduce heating during cell alignment and cell membrane contact.
The waveform generator., has two functions. The first is to produce the AC voltage waveform that is converted into an AC field by the electrod device. This AC field then brings the cells into alignment/contact. The second function is to produce a pulse voltage that electroporates the cell membrane, fusing the cells. In some cases another AC voltage is produced, a ter the fusing pulse 'to hold the cells in alignment until the fusion products become viable or stable.
One of "the factors for successful fusion is"the- membrane contact between the adjacent cells. The closer this contact before the fusion, pulse is applied, the- higher the efficiency of fusion. In U. Zimmermann, et al. , "Electric Field.-Induced Cell to-Cell Fusion" , J. Membrane Biol. 67, 165-182 (1982), Zimmermann points out that increasing the AC wave electric field strength just before the fusion pulse may be the optimum approach. CIearly, it would- be'•desirable-' for' biological ' cells' that are to undergo cell fusion to be pretreated with pre- fusion electric field waveforms which bring about increased cell membrane contact without turbulence or heating. In addition, there are a number of reasons why it fs not desirable to immediately provide a high amplitude alignment waveform to cells that are to undergo cell fusion. A first reason is a mechanical reason. That is, immediate application of a high amplitude alignment waveform causes extreme force to be exerted on the cells, causing the cells to move rapidly towards an electrode. This- rapid cell movement causes turbulence forces in the medium surrounding the cells. The turbulence forces do not "allow complete pearl chains' of cells' to"form,- and")the turbulence forces cause already formed pearl chains of cells to break up. A second reason why it is not desirable to- immediately provide a high amplitude alignment waveform to cells that are to undergo cell fusion is that such a hάjgh amplitude alignment waveform causes heating to occur in the media in which the biological cells are suspended. Heating also causes turbulence which does not permit complete pearl chains of aligned cells to form and causes already formed pearl chains to break up. The heat in the heated up media also reduces cell viability.
In view of the above, it would be desirable to avoid the mechanical forces, turbulence, and heating which result from immediately applying a high amplitude alignment waveform to biological cells that are to undergo cell fusion.
Thus, while the foregoing body of prior art indicates it to be well known to use pre-fusion electric field waveforms prior to carrying out cell fusion with an electroporation pulse, the prior art described above does not teach or suggest a dielectrophoresis waveform for ceT.1 fusion which has the following combination of desirable features: (1) provides pre-fusion, electric field waveforms for biological cells which increase cell fusion efficiency over biological cells treated with a constant amplitude or a linearly increasing amplitude pre-fusion electric' field' aveforms; (2) avoids the mechanical forces, turbulence, and heating which result from immediately applying a high amplitude alignment wavefoipm to biological cells that are to undergo cell fusion; (3) reduces heating of biological cells being treated wiς.h pre-fusion electric field waveforms for increasing cell alignment and cell membrane contact prior to being subjected to cell fusion; and (4) increase cell membrane contact between biological cells treated, with pre-fusion electric field waveforms prior to undergoing cell fusion. The foregoing desired characteristics are provided by the unique non-linear dielectrophoresis waveform for cell fusion of the present invention, as. will be made apparent from the following description thereof . Other advantages of the present invention, over. the. prior, art also will be rendered evident .
Additional T. S'. patents.. hat are of interest include : 4,561,961; December.31.,. 19'8"S" Hofmann
5,001,056 March 19, 1991 Snyder et al
5,589,047" December..3 .Λ- 1996'' Coster et, al 5,650,305 July 22, 1997 Hui et al
Additional literature references- include: 1. R. Bischoff, et al., "Human Hybridoma Cells Produced by Electro-Fusion", Fed. Eur. Bioche . Soc. L^tt. 147, 64-68 (1982) .
2. L. Changben, et al., "Use of Human Erythrocyte Ghosts for Transfer of 125.sub.I-BSA and 125.sub.I-DNA into Animal Cells from Ceil Fusion'.' ,... Sclentia Sinica (Series. B) 25, 680-865 (1982) .
3. C. S. Chen, et al., "Biological Dielectrophoresis : The Behavior of Lone Cells in a Non-uniform Electric Field", Ann. N'.'Y'. Acad". Sci. 238, 176.- 8-S' (19T4) . 4. Coster, H. G. L. and Zimmermann, U. "Direct
Demonstration of Dielectric Breakdown in the Membranes ptf
Valonia utricularis. " Zeitschrift fur Naturforschung. 0 c, TT-79".l"9 5.
5. Coster,'" H. G'." K." and Zimmermann,. UV." "Dielectric Breakdown in the Membranes of Valonia utricularis: the role of- energy 'dissipation"". Biσchimica' et BiophySjica Acta. 382, 410-418,1975.
6. Coster, H". G. LV and:.Zmmermann.r IT... "The mechanisms' of Electrical Breakdown in the Membranes of Valonia utricularis." Journal of Membrane" Biology. 22, 73-90, 19j75.
7. . Kaler, et al . , "Dynamic Dielectrophoretic Levitation of Living Individual Cells", J. Biol . Phys. 8, 18-31' (198p) .
8. A. R. Murch, et al. , "Direct .Evidence that Inflammatory Multi-Nucleate Giant Cells Form by Fusion!', Pathol. Sσc Gr. Britv Ire. 137, 177-180 (1982)-.
9. Neumann, Bet al . "Cell Fusion Induced by High Electrical Impulses Applied to Dictyostelium", Naturwissenschaften 67, 414, 1980
10. Petrucci,• General Chemistry,' Principles''and''Modern Applications, 4th ed., p. 621, 1985 (no month).
11. Zimmermann et al.,, Electric Field-Induced Cell-to-Cell Fusion, The Journal of Membrane Biology, voi. 67, pp-; 165-182 (1982) [no month] .
12. Pohl, H. "Dielectrophoresis", Cambridge University Press;" 19*18 .
13". H". A. Pohl, "Biάphyaical .Aspects, of Dielectrophoresis", J. Biol. Phys. 1, 1-16 (1973).
14. H. Al Pohl, et al-,. "Continuous. DlelectrophoreJric Separation of Cell Mixtures", Cell Biophys . 1, 15-28 (197-9) .
15 . H. A. Pohl , e al . ,. "Dielectrophoret±c Force"", •■ J. Biol . Phys . 6 , 133 (1978) .
16 . H. l Pohl", et al r "The. Continuous Positive and Negative Dielectrophoresis of Microorganisms" , J . Bio . Phys. 9 , 67-86 (19#1) .
17. Sale, J". H. and: Hamil.ton,. W . A__ "Effects of HfLgh Electric Fields on Micro-Organisms" , Biochimica et Biophysica A'cta. 163', 37-43, 1968.
18. Sepersu, E. H., Kinosita, K. and Tsong, T~Y. " "Reversible and Irreversible Modification of Efythrocyte Membrane Permeability by Electric Fields" Biochimica' et Biophysica A'Cta. 8X2, 779-785", 1985.
19. J. Vienken, et al . , "Electric Field-Induced Fusion: Electro-Hydraulic Procedure for Production of Heterokaryon Cells in High Yield", Fed. Eur. Biomed. Soc. Lett. 137,' 11-13 (19'8"2)' . 20. H. Weber, et al., "Enhancement of Yeast Protoplast Fusion by Electric Field Effects"",. A Preprint for-- Proceedings of the Fifth International Symposium on Yeasts, ondon, Ontario, Canada.,... JX.- &0:. 21. Zimmermann, U. "Electrical Field Mediated Fusion and Related Electrical Phenomena", Biochimica et Biophysica Acta. 694, 227-277. 1982.
22. Zimmermann, UV et al "Fusion of Avena Sativa Mesophyll Proptoplasts by Electrical Breakdown" , Biochimica et Biophysica Acta. 64X, 160-X6S, 198-Xϊ 1982.
23. U. Zimmermann, et al . , "Electric Field-Induced Release of Chloroplasts from Plant Protoplasts", Naturwissen 69, 451 (1982) .
24. U Zimmermann, et al". , "Electric Field-Mediated' Cell Fusion", J. Biol. Phys. 10, 43-50 (1982).
25". UV Zimmermann, "Cells with Manipulated Functions: New Perspectives for Cell Biology, Medicine, and Technology", Angew. C em. Iht. Ed. Engl. 20, 3 5-344" (198,1) .
Disclosure of Invention The present invention is an improvement over the current art. With the present invention, a non-linear- voltage waveform having a non-linear change in amplitude is- applied"to' biological, cells: before'.application"of one or more cell fusion/electroporation pulses. The present invention first brings about or. forces tangential, membrane contact and alignment between adjacent cells as a result of' applying-th 'non-linear' voltage..',waveluxm.''' Then, the present invention brings about or forces close membrane contact between adjacent cells as a result of further application of the non-linear voltage waveform. In this respect, the' biological cells•ID' are compressed'•against- each other under the influence of the waveform with a nonlinear change in amplitude. The biological cells can.be similar Eukaryotic cells, or they can be dissimilar Eukaryotic cells". The pre-fusion non-linear voltage waveform, which changes' in"amplitude ln"a' non-linear' way, can"be"a' nonlinear AC voltage waveform. The AC electric field waveforms can include sine waves. A" parameter of the- non-linearity of the change in amplitude of the waveform can 'be' set so' that the'f sion- process' can"be"op imized "by cell type. With the amplitude of the AC waveform varyirilg non-linearly in amplitude over time, the biological cells align and fuse with lower energy (less heating) and with higher fusion"efficiency.
Preferably, the pre-fusion electric field waveform includes a relatively low amplitude, long duration electric field waveform followed by a relatively short duration, high amplitude electric field waveform. More specifically, the relatively low amplitude, long duration electric field waveform slowly facilitates pearl chain' formation and alignment of biological cells without-, causing turbulence or cell death. Once the cells are aligned and in pearl chains, a relatively high amplitude, short duration pre-fusion electric field waveform is applied to the biological cells. The cells are already^ in alignment, and for a short period of time, before heating occurs, cell compression takes place without turbulence.
The pre-fusion electric field waveform amplitude can change in a stepped non-linear way with respect to time. The pre-fusion electric field waveform can change in amplitude in a continuous non-linear way with respect • to time.
The pre-fusion electric field waveform includes an AC electric field waveform which changes in amplitude in" a non-linear way with respect to time. The amplitude of the AC electric field waveform can change in a non-linear way with respect to time in accordance with a non-linear algorithm. Preferably, the AC electric field waveforms have an AC waveform electric field intensity between 10 volts/cm and" 1, 000' volts/cm-. The non-linear step-wise amplitude increasing waveforms can be applied as pre-fusion electric field' waveforms in either adjacent steps or non-adjacent steps. Subsequent to applying the pre-fusion electric field waveform which changes in amplitude in a non-linear way, the biological cells are subjected, to a cell fusion pulse. In addition, the biological cells can be treated with a non-linear AC electric field waveform following the qell fusion pulse. There are a number of embodiments of a non-linear waveform whose amplitude changes in a non-linear way with respect to time such as wherein a pre-fusion type of AC, amplitude changes with time. Examples of algorithms "that can be used for the non-linear change in amplitude over time include exponential, logarithmic, polynomial, power function, step function, sigmoid function, and non-linear algorithms generally, etc..
In view of the above, an object of the present- invention is to provide a new and improved non-linear pre- fusion electric field waveform whose amplitude changes in a non-linear way with respect to time as a dielectrophoresis waveform prior to cell fusion.
Another object of the invention is to provide a nonlinear dielectrophoresis waveform for cell fusion in which AC electric field waveforms applied to the biological cells increase cell fusion efficiency over biological cells treated with a constant amplitude or a linearly increasing amplitude pre-fusion electric field waveform. Yet another object of the present invention is to provide a new and improved non-linear dielectrophoresis waveform for cell fusion which reduces heating of biological cells being treated with pre-fusion electric field waveforms, for increasing cell alignment and cell membrane contact prior to being subjected to cell fusion. Still another object of the present invention is to provide a new and improved non-linear dielectrophoresis waveform for cell fusion that avoids the mechanical forces, turbulence, and heating which result when the biological cells are subjected to a cell fusion from immediately applying a high amplitude alignment waveform to biological cells that are to undergo cell fusion. Even another object of the present invention is uo provide a new and improved non-linear dielectrophoresis waveform for cell fusion that increases cell membrane contact between biological cells treated witlr pre-fusion electric field waveforms prior to undergoing cell fusion. These together with still other objects of the invention, along with the various features of novelty which characterize the invention, are pointed out with particularity in the claims annexed to and forming a part of this disclosure. For a better understanding of the invention, its operating advantages and the specific objects attained by its uses, reference should be had to, the accompanying drawings and descriptive matter in which there are illustrated preferred embodiments of the invention.
Brief Description of Drawings
The invention will be better understood and the above objects as well as objects other than those set forth above will become more apparent after a study of the following detailed description thereof. Such description makes reference to the annexed drawing wherein:
Fig. 1 illustrates PRIOR ART dipole formation in biological cells under the influence of a non-uniform electric field created by non-symmetrical electrodes.
Fig. 2 illustrates a PRIOR ART path of movement of a biological cell in a non-uniform electric field created by non-symmetrical electrodes and also illustrates pearl chain alignment and formation of biological cells.
Fig. 3 illustrates PRIOR ART a constant amplitude pre-fusion electric field waveform. Fig- 4 illustrates PRIOR ART a linearly increasing amplitude pre-fusion electric field waveform. Fig. 5 illustrates an overall general PRIOR ART protocol for• carryin ' out cell fusion' using- electric''f ^d waveforms, wherein a pre-fusion electric field waveform is followed by a fusion/electroporation pulse, which is followed by a post-fusion electric field waveform.
Fig. 6 shows independent" biological cells"prior) to i applying non-linear dielectrophoresis waveforms of the invention.
Fig. 7 shows tangentially contacting biological, cells in pearl chain alignment during application of' a relatively low amplitude, long duration pre-fusion electric field waveform of the invention.
Fig. 8 shows closely contacting and compressed- biological cells during application of a relatively high amplitude, short duration pre-fusion electric field- waveform of the invention, following the application of the relatively low amplitude, long duration pre-fusion electric field waveform that was applied in Fig. 7.
Fig. 9 shows variations in pre-fusion electric field waveforms applied to biological cells using a power function having variations in the constant "k" of the-, power function. It is noted that for each selection of the constant "k", there is a relatively low amplitude-, long duration pre-fusion electric field waveform portion followed by a relatively high amplitude, short duration pre-fusion electric field waveform portion.
Fig. 10 shows a selected "k" modulated non-linear increasing continuous AC waveform applied as a pre-fusiόn electric field AC waveform as a power function with a selected power function constant "k" shown in Fig. 9, a relatively low amplitude, long duration pre-fusion- electric field waveform portion is shown followed by" a relatively high amplitude, short duration pre-fusion electric field waveform portion. Fig. 11 shows non-linear sigmoidally shaped waveforms applied as pre-fusion electric field waveforms, wherein a transition from a relatively low amplitude, long duration pre-fusion electric field waveform to a relatively high amplitude, short duration pre-fusion electric field waveform is relatively slow.
Fig. 12 shows non-linear sigmoidally shaped" waveforms applied as pre-fusion electric field waveforms, wherein a transition from a relatively low amplitude, long duration pre-fusion electric field waveform to a relatively high amplitude, short duration pre-fusion electric field waveform is relatively fast. Fig. 13" shows non-linear step-wise increasing- waveforms applied as pre-fusion electric field waveforms, wherein the pre-fusion electric field' waveforms are' provided as non-adjacent steps, wherein a first pre-fusion electric field waveform is a relatively low amplitude, long duration pre-fusion electric field waveform, wherein an off-time is provided, and wherein a second pre-fusion electric field waveform is a relatively high amplitude, short duration pre-fusion electric field waveform. Fig. 14 shows non-linear step-wise increasing waveforms applied as pre-fusion electric field" aveforms, wherein the pre-fusion electric field waveforms are provided as adjacent steps, wherein a first pre-fusion electric field waveform is a relatively low amplitude, long duration pre-fusion electric field waveform, and wherein a second pre-fusion electric field waveform is a relatively hig amplitude, short duration pre-fusion' electric field waveform and is applied immediately after the first pre-fusion electric field' waveform.
Modes for Carrying Out the Invention
A method and apparatus are provided for non-linear dielectrophoresis waveform for cell fusion, and with reference to the drawings, said method and apparatus are described below. ' The present invention is an improvement over the current 'art. With the present invention, a non-linear voltage waveform, whose amplitude changes in a non-linear way, is applied to biological cells' before application of one or more cell fusion pulses. Separated biological cells 10 are shown in Fig. 6. The present invention first brings about or forces tangential membrane contact betwe'en adjacent cells'as' a "result' of' applying-"the' non-linear voltage waveform, as shown in Fig. 7. Then, the present invention brings about or forces close membrane contact between adjacent cells as a result of applying the noh- linear"voltage waveform", as' shown"in' Fig-.' 8'. As'shσ ni in Fig. 8, the biological cells 10 are compressed against each other under the influence of the non-linear voltage waveform.
The non-linear"voltage■waveformy•■whose'•amplitjude changes in a non-linear way, can be a non-linear AC voltage waveform. A parameter of the non-linearity of the waveform can be set so that the fusion process can be optimized"'bycell type. With" he amplitude' of the' AC waveform varying non-linearly over time, the biological cells align and fuse with lower energy (less heating) and with higher fusion efficiency.
More' specifically, with 'reference' tσ Fig; 10, with, a non-linear AC voltage waveform, preferably the non-linear AC'voltage waveform has a relatively low AC voltage- amplitude at the first portion of the waveform that brings the biological' cells into' close proximity and' alignment . A second portion of the waveform then increases in amplitude just before the fusion pulse is to be applied. This increase in amplitude produces a short-term, intense, and"non-uniform"electric field, which' forces' the biological cells into close contact. Heating is reduced, due to the lower voltage used for alignment and t.he shorter duration intense AC portion.
There are • number of"embodimen s"of' this' type' of AC amplitude change with time, for example, exponential, logarithmic, polynomial, power function, step function, sigmoid function, and non-linear algorithm generally, etc..
One embodiment of this non-linear waveform is a power function that may be represented by the following mathematical formula or algorithm.
The amplitude of the AC waveform as a function of time =
[ (Time/Total AC duration)k x (Stop Amplitude - Start
Amplitude) ] - Start Amplitude
The total AC waveform duration, the AC starting amplitude, the AC stopping amplitude and the power exponent "k" are all optimized for" the cells type bejLng used.
The effect of varying the power exponent "k" is illustrated by the graphs in Fig. 9. A particular power function graph is- illustrated in Fig. 10 where "k" equals 2. Thus, the invention provides a relatively low amplitude, long duration pre-fusion electric field waveform that produces a lower intensity electric field to align the biological cells and that then provides a, relatively high amplitude, short duration pre-fusi n electric field waveform of increased electric field- intensity to force the cells into close contact, just before- the AC wave ends and the cell fusion/electroporation pulses begins. This non-linear change in amplitude approach of the invention also produces less heating and less turbulence, which further provide an increase in cell hybrid production and production efficiency. As stated above, in Fig. 10 there is a showing of non-linear, amplitude increasing continuous waveforms applied as pre-fusion electric field waveforms as a power function with a selected power function constant of "k" equals 2. Fig. 11 shows non-linear sigmoidally shaped waveforms, whose amplitudes change in a non-linear way, applied as pre-fusion electric field waveforms, wherein"a transition from a relatively low amplitude, long duration pre-fusion electric field waveform to a relatively high amplitude, short duration pre-fusion electric field waveform is relatively slow.
Fig. 12 shows non-linear sigmoidally shaped waveforms, whose amplitudes change in a non-linear way, applied as pre-fusion electric field waveforms, wherein a transition from a relatively low amplitude, long duration pre-fusion electric field wavefσrπr to a relatively high amplitude, short duration pre-fusion electric field waveform is relatively fast. Fig. 13 shows non-linear step-wise increasing waveforms, whose amplitudes change in a non-linear way, applied as pre-fusion electric field waveforms, wherein the pre-fusion electric field waveforms are provided as non-adjacent steps, wherein a first pre-fusion electric field waveform is a relatively low amplitude, long duration pre-fusion electric field waveform, wherein "an off-time is provided, and wherein a second pre-fusion, electric field waveform is a relatively high amplitude, short duration pre-fusion electric field waveform,. Fig. 14 shows non-linear step-wise increasing waveforms, whose amplitudes change in a non-linear way, applied as pre-fusion electric field waveforms, wherein the pre-fusion electric field waveforms are provided as adjacent steps, wherein a first pre-fusion electric field waveform is a relatively low amplitude, long duration pre- fusion electric field waveform, and wherein a second pre- fusion electric field waveform is a relatively high amplitude, short duration pre-fusion electric field waveform and is applied immediately after the first p|re- fusion electric field waveform.
The present invention can be carried out by an- apparatus that delivers such pre-fusion electric field wavefor s described above. In this respect, a software' modification has been made to the Cyto Pulse PA-4000' system with the PA-101 AC waveform generator. This Cyto Pulse Sciences, Inc. PulseAgil'e(Reg. UIS. Pat. and Trtr. Off.) system software now produces this waveform (see U. S. Patent 6, 0X0, 613 incorporated herein by reference). The non-linear AC waveform parameters are inputted by the user, and the computer generates the AC waveforms (pre- fusion electric field waveforms) and fusion pulse waveforms (electroporation waveforms) .
Experiments were carried out, and improvements f cell fusion were recorded using stepped pre-fusion electric field waveforms whose amplitudes change in a nonlinear way. A549 cells were purchased from the ATCC." The. cells were thawed and placed in tissue culture flasks with medium' recommended' b ATCC Dendritic cells "prepared";by culture of peripheral blood mononuclear cells in a mixture of cytokines for 7' days were used as fusion partners.
8 million cells/' milliliter of each cell type were, mixed equally to yield a final concentration of 4 million cells/ milliliter of each cell type in the mixture. Cell suspension volumes of 3 milliliters were used for each fusion.
"" The procedure consisted of the following steps. Cells were centrifuged and re-suspended in 10 milliliters of Cyto Pulse commercial Cytofusiσn medium (formula C) The cells were washed twice in the same medium and re-suspended in Cytofusion medium after the washes. Cells were counted and the cell concentration was adjusted to" 8 million cells/milliliter. Equal volumes of A54'9 cells and dendritic cells were mixed. Three milliliters of cell suspension was place into a 6 milliliter capacity coaxial cell fusion electrode, having an internal cylindrical anode of 3.9 cm diameter with a gap of 4 mm from the cathode. The following cell fusion protocols were applied.
The parameters for the two experimental and pne control groups are as follows: Group A: (Invention)
First pre-fusion electric field waveform: 45 V to 45 V, 20 Seconds, 0.8 MHz
Second pre-fusion electric field waveform: 75 V to 75, V. 10 seconds, 0.8 MHz Fusion/electroporation pulse IX 800 V, 40 microseconds Post fusion/electroporation pulse 45 V to 45 V, 50 seconds, 0.8 MHz-
Group B: (Prior Art)
First pre-fusion electric field waveform: 75 V to 75 V. 10 seconds, 0.8 MHz
Fusion/electroporation pulse IX 800 V, 40 microseconds Post fusion/electroporation pulse 45 V to 45 V, 50 seconds, 0.8 MHz
Group C: (Control--no electricity) After fusion, cells were left undisturbed for 30 minuses to allow fusion maturation. Three milliliters of tissue culture medium with 10% fetal bovine serum were added to the cell suspension in the cell fusion electrode. Fifteen minutes later the cells were harvested for analysis.
An aliquot of cells was placed onto a silinized, microscope slide using a commercial Cytospin (Shandon) centrifuge. The cells were identified using immunohistochemistry. A549 cells were identified using anti-keratin monoclonal antibodies and the dendritic cells were identified by using anti human HLA-DR monoclonal antibodies. Meyers hematoxylain was used for a nuclear counterstain. The cells with either brown keratin staining or red HLA-DR staining or both were manually counted. Results are shown in the TABLE below in which percentages' of "fused "cells' are" presented" for"mixed"A549- and dendritic cells in Group A (which were treated with' a pre-fusion electric field waveform of the invention prior to cell fusion) , for mixed A549 and dendritic cells in Group B (which "were treated by a" prior art pre-fusion electric field waveform prior to cell fusion) , and for mixed A549 and dendritic cells in Group C (which were not treated by any pre-fusion electric field waveform at ail prior- to cell fusion) .
TABLE"
Group Fused Fused Fused
A549/A54 ' den. /den. den./A549
A (Invention) 7.2% 5.4% 22.7% B (P .Art) 6.8% 4.0% 18.1%
C (Control) 2.2% 2.2% 10.3%
By way of explanation of the TABLE, the first column lists the respective groups of A549 and dendritic cells (den.) that were subjected to fusion treatment. The- second column lists the percentages of fused cells formed by the fusion of an A549 " cell with another A54 cell. The third column lists percentages of fused cells formed by the fusion of a dendritic cell with another dendritic cell . The fourth column lists percentages of fused cells formed by the fusion of a dendritic cell with an A549 cell.
It is noted that for each type of cell fusion- (A549/A549, den. /den., and den./A549), the percentages of fused cells are greater with Group A" (employing a pre- fusion electric field waveform of the invention) than with either Group B" (employing a pre-fusion electric field- waveform of the prior art) or Group C (employing no pre- fusion electric field waveform at all)' . More specifically, 7.2% is greater than 6.8%, which is greater than 2.'2%'. Also, 5.4% is greater than 4.0%, which is greater than 2.2%. Also, 22.7% is greater than 18.1%, which is greater than 10.8%. In summary, employing a pre- fusion electric field waveform of the invention provides higher fusion efficiency than employing either a prior art pre-fusion electric field waveform or no pre-fusion electric field waveform at all.
As to the manner of usage and operation of the present invention, the same is apparent from the above disclosure, and' accordingly, no further discussion relative to the manner of usage and operation need "be provided.
'It is apparent from the above that the present invention accomplishes all of the objects set forth by providing new and improved non-linear dielectrophoresis- waveforms for cell fusion which may advantageously be used to provide pre-fusion electric field waveforms for biological cells which increase cell fusion efficiency over biological cells treated with a constant amplitude or a linearly increasing amplitude pre-fusion electric field waveform. With the invention, non-linear dielectrophoresis waveforms avoid the mechanical forces, turbulence, and heating which result from immediately applying a high amplitude alignment waveform to biological cells that are to undergo cell fusion. With the invention, non-linear dielectrophoresis waveforms reduce heating of biological cell's being treated with pre-fusion electric field waveforms for increasing cell alignment and cell membrane contact prior to being subjected to cell fusion. With the invention, non-linear dielectrophoresis waveforms increase cell membrane contact between biological cells treated with pre-fusion electric field waveforms prior to undergoing cell fusion.
Thus, while the present invention has been shown in the drawings and fully described above with particularity and detail in connection with what is presently deemed to be the most practical and preferred embodiment (s) of the invention, it will be apparent to those of ordinary skill in the art that many modifications thereof may be made without departing from the principles and concepts set forth herein, including, but not limited to, variations in size, materials, shape, form, function and manner of operation, assembly and use.

Claims

Claims
1. A method of treating biological cells prior to subjecting the biological cells to one or more cell fusion/electroporation pulses, comprising the step of: treating the biological cells with a pre-fusion electric field waveform which changes amplitude in a nonlinear way with respect to time.
2. The method of claim 1 wherein the biological cells are first aligned and then compressed resulting in increased cell membrane contact prior to being subjected to cell fusion.
3. The method of claim 1 wherein the pre-fusion electric field waveform amplitude includes a relatively low amplitude, long duration electric field waveform followed by a relatively high amplitude, short duration electric field waveform.
4. The method of claim 1 wherein the pre-fusion electric field waveform amplitude changes in a stepped non-linear way with respect to time.
5. The method of claim 1 wherein the pre-fusion electric field waveform amplitude changes in a continuous nonlinear way with respect to time.
6. The method" of claim l wherein the pre-fusion electric field waveform includes an AC electric field waveform which changes amplitude in a non-linear way with respect to time.
7. The method of claim 6 wherein the amplitude of said] AC electric field waveform changes in a non-linear way with respect to time in accordance with a non-linear algorithm.
8. The method of claim 6 wherein said AC electric field waveform has an AC'waveform electric field intensity between 10 volts/cm and 1,000 volts/cm.
9. The' methσd'of claim' 1' wherein" the"pre-fusion" electric field waveform amplitude includes non-linear step-wise increasing waveforms applied as pre-fusion electric fie,ld waveforms, and wherein the waveforms are provided as either- adjacent steps or"non-adacent steps-.-
10. The method of claim 1, further including the steps of: subjecting the biological ceils to a cell fusion pulse, and treating the biological cells with an AC electric field waveform following the cell fusion pulse.
11. A method of treating biological cells prior to- subjecting the biological cells to cell fusion, comprising the step of: treating the biological cells with an electric field amplitude which changes in a non-linear way with respect to "time', such that the 'biological" cells- are"aligned: and have increased cell membrane contact, and such that the biological cells are compressed against one another prior to being subjected to cell fusion.
PCT/US2002/008239 2001-08-31 2002-04-05 Non-linear amplitude dielectrophoresis waveform for cell fusion WO2003020915A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US10/487,235 US6916656B2 (en) 2001-08-31 2002-04-05 Non-linear amplitude dielectrophoresis waveform for cell fusion
DE60226501T DE60226501D1 (en) 2001-08-31 2002-04-05 DIELECTROPHORESE WAVEFORM WITH NONLINEAR AMPLITUDE FOR CELL FUSION
AU2002254269A AU2002254269A1 (en) 2001-08-31 2002-04-05 Non-linear amplitude dielectrophoresis waveform for cell fusion
JP2003525619A JP4217618B2 (en) 2001-08-31 2002-04-05 Nonlinear amplitude dielectrophoresis waveform for cell fusion
CA2458610A CA2458610C (en) 2001-08-31 2002-04-05 Non-linear amplitude dielectrophoresis waveform for cell fusion
EP02723493A EP1472358B1 (en) 2001-08-31 2002-04-05 Non-linear amplitude dielectrophoresis waveform for cell fusion

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31593601P 2001-08-31 2001-08-31
US60/315,936 2001-08-31

Publications (2)

Publication Number Publication Date
WO2003020915A2 true WO2003020915A2 (en) 2003-03-13
WO2003020915A3 WO2003020915A3 (en) 2004-09-02

Family

ID=23226725

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/008239 WO2003020915A2 (en) 2001-08-31 2002-04-05 Non-linear amplitude dielectrophoresis waveform for cell fusion

Country Status (9)

Country Link
US (1) US6916656B2 (en)
EP (1) EP1472358B1 (en)
JP (1) JP4217618B2 (en)
CN (1) CN100591772C (en)
AT (1) ATE394499T1 (en)
AU (1) AU2002254269A1 (en)
CA (1) CA2458610C (en)
DE (1) DE60226501D1 (en)
WO (1) WO2003020915A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3088516A1 (en) 2003-12-01 2016-11-02 Cellectis Non-uniform electric field chamber for cell fusion

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8175711B2 (en) 2002-04-08 2012-05-08 Ardian, Inc. Methods for treating a condition or disease associated with cardio-renal function
US20070135875A1 (en) 2002-04-08 2007-06-14 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US9636174B2 (en) 2002-04-08 2017-05-02 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US20070129761A1 (en) 2002-04-08 2007-06-07 Ardian, Inc. Methods for treating heart arrhythmia
US8150519B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US7853333B2 (en) 2002-04-08 2010-12-14 Ardian, Inc. Methods and apparatus for multi-vessel renal neuromodulation
US9308044B2 (en) 2002-04-08 2016-04-12 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US8774913B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for intravasculary-induced neuromodulation
US7620451B2 (en) 2005-12-29 2009-11-17 Ardian, Inc. Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US8145317B2 (en) 2002-04-08 2012-03-27 Ardian, Inc. Methods for renal neuromodulation
US8145316B2 (en) 2002-04-08 2012-03-27 Ardian, Inc. Methods and apparatus for renal neuromodulation
US8774922B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods
US6978174B2 (en) 2002-04-08 2005-12-20 Ardian, Inc. Methods and devices for renal nerve blocking
US20140018880A1 (en) 2002-04-08 2014-01-16 Medtronic Ardian Luxembourg S.A.R.L. Methods for monopolar renal neuromodulation
US20080213331A1 (en) 2002-04-08 2008-09-04 Ardian, Inc. Methods and devices for renal nerve blocking
US7162303B2 (en) 2002-04-08 2007-01-09 Ardian, Inc. Renal nerve stimulation method and apparatus for treatment of patients
US8131371B2 (en) 2002-04-08 2012-03-06 Ardian, Inc. Methods and apparatus for monopolar renal neuromodulation
US9308043B2 (en) 2002-04-08 2016-04-12 Medtronic Ardian Luxembourg S.A.R.L. Methods for monopolar renal neuromodulation
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US7937143B2 (en) 2004-11-02 2011-05-03 Ardian, Inc. Methods and apparatus for inducing controlled renal neuromodulation
EP1734111B1 (en) 2005-06-13 2020-06-24 Tosoh Corporation Cell fusion device, and method for cell fusion using the same
US8799512B2 (en) * 2005-10-19 2014-08-05 Qwest Communications International Inc. Cross-platform support for a variety of media types
US20100056391A1 (en) * 2006-12-22 2010-03-04 Trustees Of Princeton University Integrated screening assays and methods of use
JP2009273459A (en) * 2008-04-15 2009-11-26 Tosoh Corp Cell selection apparatus, and cell selection method using the same
US8652129B2 (en) 2008-12-31 2014-02-18 Medtronic Ardian Luxembourg S.A.R.L. Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation
EP2314217B1 (en) * 2009-10-23 2013-03-13 Tallinn University of Technology Method and device for fast measurement of frequency response with scalable short chirp signals
CN103313671B (en) 2010-10-25 2017-06-06 美敦力Af卢森堡有限责任公司 Device, the system and method for estimation and feedback for nerve modulation treatment
AU2013230781B2 (en) 2012-03-08 2015-12-03 Medtronic Af Luxembourg S.A.R.L. Ovarian neuromodulation and associated systems and methods
US9597018B2 (en) 2012-03-08 2017-03-21 Medtronic Ardian Luxembourg S.A.R.L. Biomarker sampling in the context of neuromodulation devices, systems, and methods
US20140110296A1 (en) 2012-10-19 2014-04-24 Medtronic Ardian Luxembourg S.A.R.L. Packaging for Catheter Treatment Devices and Associated Devices, Systems, and Methods
US9980766B1 (en) 2014-03-28 2018-05-29 Medtronic Ardian Luxembourg S.A.R.L. Methods and systems for renal neuromodulation
US10194979B1 (en) 2014-03-28 2019-02-05 Medtronic Ardian Luxembourg S.A.R.L. Methods for catheter-based renal neuromodulation
US10194980B1 (en) 2014-03-28 2019-02-05 Medtronic Ardian Luxembourg S.A.R.L. Methods for catheter-based renal neuromodulation
US9249385B1 (en) 2014-12-18 2016-02-02 City University Of Hong Kong System and method for fusing cells

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304486A (en) * 1987-10-09 1994-04-19 Baylor College Of Medicine Method of and apparatus for cell portion and cell fusion using radiofrequency electrical pulse
US6197176B1 (en) * 1990-01-03 2001-03-06 Btg International Limited Manipulation of solid, semi-solid or liquid materials

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3104995B2 (en) * 1991-01-31 2000-10-30 ワーナー−ランバート・コンパニー Substituted heteroaryl analogs of 4,6-di-tert-butyl-5-hydroxy-1,3-pyrimidine useful as anti-inflammatory agents
US5173158A (en) * 1991-07-22 1992-12-22 Schmukler Robert E Apparatus and methods for electroporation and electrofusion
DE10116211A1 (en) * 2001-03-27 2002-10-10 Eppendorf Ag Chamber for the treatment of cells contained in a suspension in an electrical field

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304486A (en) * 1987-10-09 1994-04-19 Baylor College Of Medicine Method of and apparatus for cell portion and cell fusion using radiofrequency electrical pulse
US6197176B1 (en) * 1990-01-03 2001-03-06 Btg International Limited Manipulation of solid, semi-solid or liquid materials

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1472358A2 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3088516A1 (en) 2003-12-01 2016-11-02 Cellectis Non-uniform electric field chamber for cell fusion

Also Published As

Publication number Publication date
EP1472358B1 (en) 2008-05-07
AU2002254269A1 (en) 2003-03-18
US6916656B2 (en) 2005-07-12
EP1472358A4 (en) 2005-05-18
CN1592787A (en) 2005-03-09
CA2458610A1 (en) 2003-03-13
JP2005506837A (en) 2005-03-10
CN100591772C (en) 2010-02-24
CA2458610C (en) 2011-08-16
JP4217618B2 (en) 2009-02-04
WO2003020915A3 (en) 2004-09-02
US20050048653A1 (en) 2005-03-03
EP1472358A2 (en) 2004-11-03
ATE394499T1 (en) 2008-05-15
DE60226501D1 (en) 2008-06-19

Similar Documents

Publication Publication Date Title
US6916656B2 (en) Non-linear amplitude dielectrophoresis waveform for cell fusion
Zimmermann et al. Electromanipulation of mammalian cells: fundamentals and application
US5098843A (en) Apparatus for the high efficiency transformation of living cells
CA2926068C (en) Apparatus for generating electrical pulses and methods of using the same
US4663292A (en) High-voltage biological macromolecule transfer and cell fusion system
Vienken et al. Electric field-induced fusion: electro-hydraulic procedure for production of heterokaryon cells in high yield
US20030186430A1 (en) Cell lysis device
Fuhr et al. High-frequency electric field trapping of individual human spermatozoa.
Saunders et al. Effects of Electroporation Pulse Wave on th e Incorporation of Viral RNA into Tobacc o Protoplasts
Scheurich et al. Membrane fusion and deformation of red blood cells by electric fields
Stenger et al. Optimization of electrofusion parameters for efficient production of murine hybridomas
Hui et al. [16] Electrofusion of cells: Hybridoma production by electrofusion and polyethylene glycol
CA2263720A1 (en) Method and apparatus for treating materials with electrical fields having varying orientations
US7824901B2 (en) Non-uniform electric field chamber for cell fusion
US4784954A (en) Procedure and device for the fusion of cells
Chang Cell fusion and cell poration by pulsed radio-frequency electric fields
Fikus et al. Electrofusion of Neurospora crassa slime cells
EP1299523B1 (en) Method for the modification of biological cells
Bertsche et al. Nuclear membrane fusion in electrofused mammalian cells
Pohl et al. The electrofusion of cells
Berg Electrofusion of cells
Novickij et al. Different permeabilization patterns of splenocytes and thymocytes to combination of pulsed electric and magnetic field treatments
Akiyama et al. Influence of 60 ns pulsed electric fields on embryonic stem cells
WO2007081631A2 (en) Method of producing insulin-secreting cells from adult stem cells via transfection
MacDonald et al. Biological cell alignment for electrofusion

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA CN JP KR

Kind code of ref document: A2

Designated state(s): AU CA CN JP KR US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB IE IT LU MC NL PT SE TR

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2458610

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003525619

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002723493

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 20028200276

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 10487235

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2002723493

Country of ref document: EP